Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework (2nd stage)



Àrea gestora

Oficina de Projectes Internacionals

Entitat convocant

No aplica


IMI2 - Innovative Medicines Initiative 2016

Àrea temàtica

No aplica

Tipus d'ajut

PJE_Projectes Europeus


  • Grups de Recerca (GRU)
  • Investigadors/es (INV)


A large amount of high-quality health data is collected during clinical studies (interventional and non-interventional), but, beyond the immediate objectives of the study, these valuable data are not used to the extent they merit. Subject to appropriate legal grounds, these data could be used to enrich patients? healthcare records to improve clinical decision-making and reduce duplication in procedures/investigations. In addition, returning clinical trial data to patients could allow them to contribute their data for additional scientific research (e.g. patient-powered research), in particular for rare diseases where treatments and data are scarce or unavailable. Finally, the lack of transparency and sharing of clinical trial data could contribute to the lack of patient willingness to be involved in studies, delays in clinical study set up and conduct, and delays in conducting health research in Europe to the detriment of vulnerable patients and public interest in general.

Bases de la convocatòria

Consultar bases

Web amb més informació

Consultar web

Data de publicació


Data d'inici presentació de sol·licituds


Termini intern (presentació sol·licituds UAB)

No aplica

Termini oficial (presentació sol·licituds organisme convocant)


Data de resolució prevista



No aplica